4.3 Article

MAO inhibitors: Risks, benefits, and lore

期刊

CLEVELAND CLINIC JOURNAL OF MEDICINE
卷 77, 期 12, 页码 859-+

出版社

CLEVELAND CLINIC
DOI: 10.3949/ccjm.77a.09103

关键词

-

资金

  1. Medtronic

向作者/读者索取更多资源

Monoamine oxidase (MAO) inhibitors were the first antidepressants introduced, but their use has dwindled because of their reported side effects, their food and drug interactions, and the introduction of other classes of agents. However, interest in MAO inhibitors is reviving. Here, we discuss their use, risks, and benefits in clinical medicine.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.3
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据